Adaptogen

Summary

An adaptogen is a substance (most often an herb or fungus) said to help an organism withstand physical, chemical, or biological stress without doing harm or simply stimulating one organ at the expense of another. The term originated in Soviet pharmacology in the mid-twentieth century, when researchers studying combat and industrial performance needed a word for plants that appeared to increase resilience without side effects. The formal criteria, set down by 1964, required that a candidate be non-toxic, that its benefits be non-specific (helping across many types of stress rather than one), and that its action be normalizing rather than pushing the body in one direction. These criteria were influential but also vague enough to be contested. Biomedical mainstream research has not adopted the category as a formal class, and the qualifying herbs have shifted over time. Historians of herbal medicine have noted that adaptogens are largely a relabeling of older tonic and alterative categories under the language of stress physiology.

Origin: Soviet Pharmacology and the Brekhman Criteria

The Soviet pharmacologist Nikolai Lazarev coined the term “adaptogen” in 1947 to describe substances that produced a non-specific increase in organismal resistance. His work at the Institute of Biologically Active Substances in Vladivostok aimed to identify botanical agents that could improve performance under demanding physical and environmental conditions. Hoffmann’s Medical Herbalism (2003) records the formal definition as it had been standardized by later researchers: adaptogens must show “a nonspecific activity — that is, increase the body’s ability to resist physical, chemical, or biological noxious agents,” “have a normalizing influence independent of the nature of the pathological state,” and “be innocuous and not influence normal body functions more than required.”(Hoffmann, David, 2003) (Hoffmann, David, 2003) The repetition of this definition across both the nervous system chapter and the herbal actions chapter of Hoffmann’s textbook suggests it had achieved near-canonical status in English-language phytotherapy by the early 2000s.

The three criteria deserve careful reading. The first (non-specific activity) is what distinguishes the adaptogen from an ordinary tonic or stimulant: it should help against any type of stressor, not only a particular one. The second (normalizing influence) means the herb moves the body toward homeostasis regardless of the direction of the deviation, whether up or down, excess or deficiency. This bidirectional character is unusual in pharmacology, where most agents are directional. The third (innocuousness) excludes substances that produce their effects by temporarily suppressing or exciting specific systems in ways that carry a rebound cost.

The physiological framework behind the definition was Hans Selye’s general adaptation syndrome (GAS).(Hoffmann, David, 2003) Hoffmann describes Selye’s three-stage model (alarm, resistance, and exhaustion) as the theoretical foundation for understanding why adaptogens are needed.(Hoffmann, David, 2003) Adaptogens moderate the stress response by smoothing blood glucose highs and lows, enabling a more rapid but less exaggerated rise, a sustained peak, and a gradual decline.(Hoffmann, David, 2003) The proposed mechanism was articulated in metabolic terms: blood glucose rises more quickly after stress onset but does not climb as high, remains elevated for a longer period, and then declines more gradually.(Hoffmann, David, 2003)

Adaptogen as a Relabeling of the Tonic and Alterative Traditions

Tobyn, Denham, and Whitelegg’s Western Herbal Tradition (2011) states that the modern concept of alterative has been “variously restyled as ‘adaptogen’, ‘immunomodulator’, and ‘depurative’, but each relabeling reflects shifting medical paradigms rather than new understanding of the underlying mechanism.”(Tobyn Denham Whitelegg, 2011) The alterative, as defined in the nineteenth-century herbalist tradition, was a medicine that “effect[s] a gradual cure by correcting the general diseased habit of body without producing a very visible effect.”(Tobyn Denham Whitelegg, 2011)

This observation connects to a broader pattern in the history of herbal action categories. When the dominant theoretical framework of medicine changes, plant remedies are not discarded; their use-patterns persist while the explanatory vocabulary is updated. Bartram, Tobyn notes, is openly aware of this when he uses “adaptogen” in contexts where “physiomedical or humoral concepts of disease are no longer current.” The underlying clinical observation about certain plants supporting systemic resilience has not changed; only the conceptual register has.(Tobyn Denham Whitelegg, 2011)

Hoffmann defines alteratives as herbs that “gradually restore proper function to the body and increase overall health and vitality,” acknowledging frankly that “their mode of action on the body is not understood.”(Hoffmann, David, 2003) He acknowledges the folk concept of “blood cleansing” as an imprecise explanation while affirming the clinical value of alteratives in holistic health care.(Hoffmann, David, 2003)

The connection to older categories runs further still. Hoffmann’s normalizer/effector distinction, in which normalizers are gentle tonic herbs that “support natural processes of growth, health, and renewal” while effectors produce more visible, directional effects, maps the same conceptual space the adaptogen inhabits.(Hoffmann, David, 2003) Vitex agnus-castus, which Hoffmann describes as a “normalizer” that “will tend to move the body back to normal function, regardless of which female hormone is involved and whether the problem is an excess or a deficiency,” displays the bidirectional quality that the Soviet criteria required.(Hoffmann, David, 2003) The language is different; the therapeutic observation is the same.

Mechanism: Two Registers

Modern phytotherapy holds the adaptogen concept in two registers simultaneously, and each requires some account of mechanism.

In the clinical-traditional register, adaptogens moderate the stress response.(Hoffmann, David, 2003) Hoffmann’s nervous system chapter places adaptogens within a taxonomy of nervine herbs that includes tonics, relaxants, stimulants, hypnotics, analgesics, antispasmodics, and antidepressants.(Hoffmann, David, 2003) The mechanism is stated at the level of systems physiology: smoothing blood glucose highs and lows, enabling a more rapid but less exaggerated rise, a sustained peak, and a gradual decline.(Hoffmann, David, 2003)

In the pharmacological register, the honest position in the current evidence base is that specific mechanisms remain under investigation and no single constituent class accounts for the adaptive effect. Hoffmann is explicit on this: “specific cellular mechanisms remain unknown while generalized effects on the pituitary-adrenal axis have been observed.”(Hoffmann, David, 2003) Hoffmann’s standing methodological caution, that “the action of a whole plant is always more than the action of any specific constituent chemical”(Hoffmann, David, 2003), applies here with particular force. Research into constituents such as ginsenosides and withanolides has identified plausible mechanisms for individual compounds in canonical adaptogens, but these constituent-level findings do not straightforwardly account for the normalizing, bidirectional, non-specific quality that the category definition requires.

The Canonical Examples

Hoffmann’s nervous system chapter provides a list of herbs that he names as fulfilling adaptogen criteria: Panax ginseng (Korean ginseng), Panax quinquefolius (American ginseng), Eleutherococcus senticosus (Siberian ginseng), Withania somnifera (ashwagandha), Lentinus edodes (shiitake mushroom), and Schisandra chinensis (schizandra).(Hoffmann, David, 2003) Hoffmann notes that most of these plants are used primarily in Asian countries, and that this is because only Asian scientists have received research grants to study them.(Hoffmann, David, 2003)

Brief orientations for the primary herbs:

Eleutherococcus senticosus (Siberian ginseng, eleuthero) was the herb most studied in Soviet-era adaptogen research, having been used extensively in trials with athletes, cosmonauts, and industrial workers. Its association with the adaptogen concept is closest to the original Brekhman research program, which involved trials with athletes, cosmonauts, and industrial workers.

Panax ginseng (Korean ginseng) is the tonifying herb most widely recognized across both Asian and Western traditions. In Chinese medicine it occupies the category of qi tonics; in European phytotherapy it came to be labelled adaptogenic.

Withania somnifera (ashwagandha) is the Ayurvedic rasayana herb most commonly placed in the adaptogen category by Western phytotherapists. The rasayana tradition, in which herbs are said to nourish tissues, restore vitality, and slow ageing, is the closest traditional precursor outside the Soviet framework to the adaptogen concept.

Rhodiola rosea became prominent in Western adaptogen discussions from the late 1990s onward, particularly through research on altitude stress and cognitive performance.

Schisandra chinensis appears in Hoffmann’s list and has an established place in both Chinese and Russian medical traditions.

Critique and Open Questions

The contestation surrounding adaptogens operates at several levels.

Definitional looseness. The three Soviet criteria, while elegant in outline, are difficult to apply rigorously. “Nonspecific resistance” is not a standard pharmacological endpoint; it must be operationalized differently for each type of stressor studied. “Normalizing influence” implies bidirectionality (raising what is low, lowering what is high), but this is rarely demonstrated cleanly in a single experimental model. “Innocuous” is a relative term that depends on dose, duration, and the population studied. Because the criteria are not measurable in a unified way, different researchers have applied them differently, and the list of herbs called adaptogens has expanded considerably since the Soviet era.

Biomedical non-recognition. The adaptogen category does not appear in standard pharmacological classification systems. This is partly a consequence of the whole-plant problem: adaptogens are defined by a systemic, multi-system effect that does not fit neatly into receptor-target pharmacology. The absence of biomedical recognition does not settle the clinical question, but it does mean that the evidence base is thinner and more heterogeneous than for drug classes defined by single-target mechanisms.

Immunomodulator overlap. Hoffmann’s chapter on the immune system distinguishes immunostimulation from immunomodulation, arguing that an overemphasis on specific plant immunostimulants is “little more than ‘organic drug therapy,’ which is not the goal of the holistic herbalist.”(Hoffmann, David, 2003) The immunomodulator category overlaps substantially with adaptogen, and the distinction between them (adaptogens operate on the stress-response axis; immunomodulators operate on immune signaling) is not always observed in clinical practice or in herbal marketing. Tobyn’s historiographic point applies here too: immunomodulator is one more relabeling of the same cluster of clinical observations.(Tobyn Denham Whitelegg, 2011)

The single-constituent problem. Hoffmann’s insistence that “the action of a whole plant is always more than the action of any specific constituent chemical” is a standing challenge to constituent-reductive pharmacology in this area.(Hoffmann, David, 2003) If the adaptogenic effect is genuinely whole-plant and complex, then isolating ginsenosides or withanolides cannot fully account for it. But if the effect cannot be attributed to identifiable constituents, it becomes difficult to study rigorously within the single-target mechanistic framework that biomedical research requires.

Scholarly Assessment

Tobyn, Denham, and Whitelegg’s Western Herbal Tradition (2011) provides the most analytically useful framing for placing the adaptogen in historical perspective. Their argument is not a dismissal of the clinical observations but a diagnosis of how herbal medicine generates new vocabulary by translating persistent clinical categories into whichever scientific idiom is current: the modern alterative has been restyled as adaptogen, immunomodulator, and depurative without any new understanding of the underlying mechanism.(Tobyn Denham Whitelegg, 2011) On this reading, adaptogens are interesting not because they represent a pharmacological discovery but because they illustrate a recurring dynamic in the history of Western herbal actions: the clinical observation outlasts its theoretical clothing.

Hoffmann’s Medical Herbalism (2003) takes a complementary position. Where Tobyn’s interest is historiographic, Hoffmann’s is clinical and taxonomic. His presentation of the adaptogen within the nervine taxonomy places it inside a practical classification of herbs by their relation to the nervous system’s response to stress.(Hoffmann, David, 2003) His account of Selye’s GAS as the physiological context gives the category a mechanistic anchor, even while conceding that specific cellular mechanisms remain unknown.(Hoffmann, David, 2003) Hoffmann’s normalizer/effector distinction further positions the adaptogen as a subset of a broader class of herbs that restore function bidirectionally rather than driving it in one direction, a class that includes herbs like Vitex, which he describes as a hormonal normalizer acting regardless of whether the deviation is excess or deficiency.(Hoffmann, David, 2003) The two framings, Tobyn’s historical and Hoffmann’s clinical, are not in conflict. Tobyn shows that the category has historical antecedents; Hoffmann shows that the category, whatever its antecedents, remains useful in practice.

See Also

• herbal-actions
• vitalism
• holism
• general-adaptation-syndrome
• stress
• alterative (page not yet written; see herbal-actions.md for current coverage)
• vis-medicatrix-naturae
• physiomedicalism

Sources

Editorial Notes

Gaps the encyclopaedia compiler flagged for future evidence work.

• [GAP: specialist source needed — Brekhman’s Eleutherococcus monographs (1969, 1980) are Soviet-era publications not in Western library catalogues; Russian-language primary criteria unattested]
• [GAP: specialist source needed — Panossian & Wikman reviews are journal articles (Phytomedicine, 2010); no pharmacology review anthology covering HSP/NPY/cortisol curves currently in Library]
• [GAP: specialist source needed — Soviet-era ginseng research history requires Russian-language secondary literature or Fulder’s The Book of Ginseng (1976); neither in Library]